ANI PHARMACEUTICALS INC (ANIP) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US00182C1036
ANI PHARMACEUTICALS INC financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 883.37 m USD |
| Gross profit | 542.06 m USD |
| Operating income | 111.09 m USD |
| EBIT | 128.35 m USD |
| Net income | 78.34 m USD |
| Diluted EPS – continuing operations | 3.32 USD |
Full history since 1998, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ANI PHARMACEUTICALS INC
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
More stocks
- Greatech Technology Bhd (0208.KL)
- Bytes Technology Group PLC (BYIT.L)
- Nuvation Bio Inc. (NUVB)
- Fastned B.V. (FAST.AS)
- CBL & ASSOCIATES PROPERTIES INC (CBL)
- Chacha Food Co Ltd (002557.SZ)
- Gs Retail (007070.KS)
- CS Wind Corp (112610.KS)
- EverCommerce Inc. (EVCM)
- DTR Automotive (007340.KS)
- U S PHYSICAL THERAPY INC /NV (USPH)
- Pell Bio-Med Technology Co., Ltd. (6949.TW)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.